US Broker Ratings

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Evaluating a 52.34% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Enliven Therapeutics, Inc. (NASDAQ: ELVN) a compelling opportunity, as the company is currently positioned with a significant potential upside of..

STAAR Surgical Company (STAA) Stock Analysis: Exploring a 37.81% Potential Upside for Investors

STAAR Surgical Company (NASDAQ: STAA), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing investment opportunity despite recent market fluctuations. Headquartered in Lake..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 20% Upside Potential in the Medical Devices Sector

iRadimed Corporation (NASDAQ: IRMD) has carved out a niche in the healthcare sector, specifically within the medical devices industry, by focusing on MRI-compatible equipment. Headquartered in Orlando, Florida, iRadimed is..

Immunome, Inc. (IMNM) Stock Analysis: A 56% Upside Potential in Biotechnology

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology company, is making waves in the healthcare sector with a focus on developing targeted cancer therapies. With a current market capitalization of $2.48..

Nutex Health Inc. (NUTX): Investor Outlook Highlights a Promising 138% Potential Upside

As healthcare remains a pivotal sector in the global economy, Nutex Health Inc. (NUTX) emerges as an intriguing player with a significant growth narrative. Operating within the United States, Nutex..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Emerging Potential with 90% Upside

For investors with a keen eye on the biotechnology sector, Nurix Therapeutics, Inc. (NASDAQ: NRIX) presents an intriguing opportunity. Headquartered in Brisbane, California, this clinical-stage biopharmaceutical company is making strides..

Geron Corporation (GERN) Stock Analysis: A Potential 108% Upside Opportunity in Biotechnology

For individual investors hunting for promising opportunities in the healthcare sector, Geron Corporation (NASDAQ: GERN) presents a compelling case with a potential upside of 108.59%. This biopharmaceutical company, headquartered in..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a Potential 18.52% Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a key player in the healthcare sector, has drawn considerable attention with its strategic focus on pain management medicines. As a specialty pharmaceutical company based..

Arcus Biosciences, Inc. (RCUS)

⚠️ No article content returned.

..

Intellia Therapeutics (NTLA) Investor Outlook: Exploring a 105% Potential Upside in Gene Editing Innovations

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneer in the burgeoning field of gene editing, is capturing investor attention with a staggering potential upside of 105.31%. The biotechnology company, headquartered in..

Salesforce, Inc. (CRM) Investor Outlook: Analyzing a 77% Potential Upside Amidst Market Volatility

Salesforce, Inc. (NYSE: CRM), a dominant player in the technology sector known for its comprehensive customer relationship management and innovative software solutions, is capturing investor attention with a significant potential..

PDF Solutions, Inc. (PDFS) Stock Analysis: Unveiling a 6.86% Potential Upside Amidst Robust Revenue Growth

PDF Solutions, Inc. (NASDAQ: PDFS), a player in the technology sector, particularly within the software application industry, is drawing attention with a market cap of $1.28 billion. With a current..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Exploring a 43% Potential Upside and Analyst Ratings

DoubleVerify Holdings, Inc. (NYSE: DV) stands as a crucial player in the Communication Services sector, specifically within the Advertising Agencies industry. Headquartered in New York, DoubleVerify offers a media effectiveness..

PAR Technology Corporation (PAR) Stock Analysis: Exploring a 172% Potential Upside

PAR Technology Corporation (NYSE: PAR) is catching the attention of investors with a staggering potential upside of 172.65%, according to analyst ratings. Operating within the technology sector, PAR specializes in..

Similarweb Ltd. (SMWB) Stock Analysis: Exploring a 167% Potential Upside

With a robust presence in the technology sector, Similarweb Ltd. (NASDAQ: SMWB) is drawing attention from investors looking to capitalize on insights-driven opportunities. As a provider of digital data and..

Paylocity Holding Corporation (PCTY) Stock Analysis: Unveiling a Potential Upside of Over 58%

For investors keeping a keen eye on the technology sector, Paylocity Holding Corporation (NASDAQ: PCTY) presents a compelling case with its robust growth metrics and significant upside potential. As a..

ALT5 Sigma Corporation (ALTS) Investor Outlook: Assessing the Growth Potential Amid a 53% Revenue Surge

ALT5 Sigma Corporation (ALTS) is drawing investor attention with its impressive 53.3% revenue growth, a standout metric in the competitive Technology sector. Operating primarily within the Software – Application industry,..

Jamf Holding Corp. (JAMF) Stock Analysis: Navigating Growth in Apple’s Ecosystem with Strong Revenue Momentum

Jamf Holding Corp. (NASDAQ: JAMF), a pivotal player in Apple ecosystem management solutions, continues to capture investor interest with its robust revenue growth, despite navigating through challenging financial metrics. With..

Kingsoft Cloud Holdings Limited (KC) Stock Analysis: A 27.71% Upside Potential with Strong Buy Ratings

Kingsoft Cloud Holdings Limited (NASDAQ: KC) is drawing significant attention in the technology sector with its robust growth potential and unanimous buy ratings from analysts. As a leading provider of..

Ribbon Communications Inc. (RBBN) Stock Analysis: An 85% Upside Potential Amidst Sector Challenges

Ribbon Communications Inc. (NASDAQ: RBBN), a notable player in the technology sector, specializes in providing cutting-edge communications technology solutions. With a market cap of $348.85 million, the company is primarily..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds